Cliff Asness's DFTX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 134,152 shares of Definium Therapeutics, Inc. (DFTX) worth $6.31 M, representing 0.00% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Cliff Asness has initiated a new position in DFTX, representing a fresh investment thesis on this company. Largest addition occurred in Q2 2026, adding 77,058 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Definium Therapeutics (DFTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Definium Therapeutics (DFTX) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +77,058 | Add 134.97% | 134,152 | $47.04 |
| Q1 2026 | +57,094 | New Buy | 57,094 | $18.90 |
Cliff Asness's Definium Therapeutics Investment FAQs
Cliff Asness first purchased Definium Therapeutics, Inc. (DFTX) in Q1 2026, acquiring 57,094 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Definium Therapeutics, Inc. (DFTX) for 2 quarters since Q1 2026.
Cliff Asness's largest addition to Definium Therapeutics, Inc. (DFTX) was in Q2 2026, adding 134,152 shares worth $6.31 M.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 134,152 shares of Definium Therapeutics, Inc. (DFTX), valued at approximately $6.31 M.
As of the Q2 2026 filing, Definium Therapeutics, Inc. (DFTX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Definium Therapeutics, Inc. (DFTX) was 134,152 shares, as reported at the end of Q2 2026.